Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?
作者信息
Eroğlu Imdat, Çelik Eroğlu Burcu, Uyaroğlu Oğuz Abdullah, Sain Güven Gülay
机构信息
Department of Internal Medicine, Faculty of Medicine, Hacettepe University; Ankara-Turkey.
Department of General Internal Medicine, Faculty of Medicine, Hacettepe University; Ankara-Turkey.
出版信息
Anatol J Cardiol. 2020 Jul;24(1):19-20. doi: 10.14744/AnatolJCardiol.2020.73232.
Abstract
摘要
相似文献
1
Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?在高危COVID-19患者中早期使用肾素-血管紧张素系统（RAS）阻滞剂、他汀类药物和肝素阻断血管紧张素：这是解决办法吗？
Anatol J Cardiol. 2020 Jul;24(1):19-20. doi: 10.14744/AnatolJCardiol.2020.73232.
2
Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.肾素-血管紧张素-醛固酮系统抑制剂治疗高血压患者可降低COVID-19死亡率：一项荟萃分析
Hypertension. 2020 Aug;76(2):e13-e14. doi: 10.1161/HYPERTENSIONAHA.120.15572. Epub 2020 May 27.
3
Meta-analysis of Effect of Statins in Patients with COVID-19.他汀类药物对新型冠状病毒肺炎患者影响的荟萃分析
Am J Cardiol. 2020 Nov 1;134:153-155. doi: 10.1016/j.amjcard.2020.08.004. Epub 2020 Aug 12.
4
Are statins safe in patients with COVID-19?他汀类药物对新冠肺炎患者安全吗？
J Clin Lipidol. 2020 Jul-Aug;14(4):396-397. doi: 10.1016/j.jacl.2020.06.009. Epub 2020 Jun 22.
5
Potential role of statins in COVID-19.他汀类药物在 COVID-19 中的潜在作用。
Int J Infect Dis. 2020 Jul;96:615-617. doi: 10.1016/j.ijid.2020.05.115. Epub 2020 Jun 2.
6
Considerations for Statin Therapy in Patients with COVID-19.新型冠状病毒肺炎患者他汀类药物治疗的考量因素
Pharmacotherapy. 2020 May;40(5):484-486. doi: 10.1002/phar.2397. Epub 2020 May 4.
7
COVID-19 in a Patient with β-Thalassemia Major and Severe Pulmonary Arterial Hypertension.一名重型β地中海贫血合并重度肺动脉高压患者的新型冠状病毒肺炎
Hemoglobin. 2020 May;44(3):218-220. doi: 10.1080/03630269.2020.1779082. Epub 2020 Jun 18.
8
Related molecular mechanisms of COVID-19, hypertension, and diabetes.新型冠状病毒肺炎、高血压和糖尿病的相关分子机制
Am J Physiol Endocrinol Metab. 2020 Jun 1;318(6):E881. doi: 10.1152/ajpendo.00164.2020.
9
10
The COVID-19 Pandemic and Mayo Clinic Proceedings.新冠疫情与《梅奥诊所学报》
Mayo Clin Proc. 2020 May;95(5):835-836. doi: 10.1016/j.mayocp.2020.04.009. Epub 2020 Apr 18.
引用本文的文献
1
Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2.新型冠状病毒肺炎患者的炎症与血栓形成：一种由严重急性呼吸综合征冠状病毒2引起的促血栓形成和炎症性疾病。
Anatol J Cardiol. 2020 Oct;24(4):224-234. doi: 10.14744/AnatolJCardiol.2020.56727.
2
Renin-angiotensin system inhibition in COVID-19 patients: Friend or foe?新冠病毒肺炎患者中肾素-血管紧张素系统抑制：是友还是敌？
Anatol J Cardiol. 2020 Jul;24(1):30-31. doi: 10.14744/AnatolJCardiol.2020.40771.
本文引用的文献
1
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
2
The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science.2019冠状病毒病、衰老与心血管疾病的困境：心血管衰老科学的见解
JAMA Cardiol. 2020 Jul 1;5(7):747-748. doi: 10.1001/jamacardio.2020.1329.
3
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
4
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?新型冠状病毒肺炎与血管紧张素转换酶抑制剂及血管紧张素受体阻滞剂：证据是什么？
JAMA. 2020 May 12;323(18):1769-1770. doi: 10.1001/jama.2020.4812.
5
Clinical features of deaths in the novel coronavirus epidemic in China.中国新型冠状病毒疫情死亡患者的临床特征。
Rev Med Virol. 2020 May;30(3):e2103. doi: 10.1002/rmv.2103. Epub 2020 Mar 16.
6
Recombinant human ACE2: acing out angiotensin II in ARDS therapy.重组人血管紧张素转换酶2：在急性呼吸窘迫综合征治疗中胜过血管紧张素II 。
Crit Care. 2017 Dec 13;21(1):305. doi: 10.1186/s13054-017-1882-z.
7
Molecular and Immune Biomarkers in Acute Respiratory Distress Syndrome: A Perspective From Members of the Pulmonary Pathology Society.急性呼吸窘迫综合征中的分子和免疫生物标志物：来自肺病理学会成员的观点
Arch Pathol Lab Med. 2017 Dec;141(12):1719-1727. doi: 10.5858/arpa.2017-0115-SA. Epub 2017 Jun 14.
8
Renin-angiotensin system inhibitor and statins combination therapeutics - what have we learnt?肾素-血管紧张素系统抑制剂与他汀类药物联合疗法——我们了解到了什么？
Expert Opin Pharmacother. 2015 May;16(7):949-53. doi: 10.1517/14656566.2015.1019464. Epub 2015 Mar 8.
9
ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury.血管紧张素转换酶2：心脏和肾脏损伤中血管紧张素II/血管紧张素-（1-7）平衡
Curr Hypertens Rep. 2014 Mar;16(3):420. doi: 10.1007/s11906-014-0420-5.
10
Heparin inhibits angiotensin II-induced vasoconstriction on isolated mouse mesenteric resistance arteries through Rho-A- and PKA-dependent pathways.肝素通过 Rho-A 和 PKA 依赖性途径抑制血管紧张素 II 诱导的离体小鼠肠系膜阻力动脉收缩。
Vascul Pharmacol. 2013 Apr;58(4):313-8. doi: 10.1016/j.vph.2012.12.003. Epub 2012 Dec 23.
Zotero 插件